Form Health Begins Prescribing Through Medicare GLP-1 Bridge Program as New Medicare Coverage Takes Effect

Source Summary

BOSTON--(BUSINESS WIRE)--Form Health, the national leader in science-based obesity and cardiometabolic care, today announced it has begun prescribing through the new Medicare GLP-1 Bridge Program, a new demonstration program that expands access to certain GLP-1 medications for eligible Medicare Part D beneficiaries with obesity. Having long accepted Medicare, Form is among the few digital healthcare providers with the clinical experience and infrastructure needed to help eligible beneficiaries